retatrutide ly3437943 triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide—A Game Changer in Obesity

Jeon, J

Beneficiaries would have a monthly copay of $50, which is less than the typical out-of-pocket cost for this class of treatments currently

Benefits: Decrease in Body Fat Decrease in weight May Suppress Appetite Improved blood sugar regulation More control over insulin Reduce food cravings Lower Inflammation Increase Cardio-Vascular Health Improve Sleep FSA & AFTERPAY AVAILABLE Your body relies on minerals and nutrients to function at its best

Hydration requires active attention because reduced food intake means less water from food sources

Canadian medication review and safety information can also support patient discussions

What drug interactions should I be aware of given my current medications